01 · Patients Treated · Last 12 Months
0
Across DAXXIFY®, RHA® Collection, and SkinPen® — every treatment compounds toward Advocate tier.
DAXXIFY®
49%
312
RHA® Collection
31%
198
SkinPen®
20%
127
02 · Approximate Revenue · vs Last Year
$0K
+18% year-over-year. A measured acceleration, driven largely by neurotoxin expansion.
vs LY$414K +18%
Per Patient$575
03 · Patient Retention · 90-Day Cohort
0%
Three-quarters return after their first treatment. Of those, the majority arrive on schedule.
04 · Month-over-Month Growth
+0%
The last quarter outpaced the nine before it — the gold bars mark this year's inflection.
AMJ
JAS
OND
JFM
A
Avg / Day12
Peak Day42
Slow Day14
05 · Patient Age Distribution
35–44
The dominant cohort in your book. Messaging that speaks to mid-career women will carry furthest.
06 · Top Lifestyle Interests
Beauty
Where your patients spend time outside the clinic — useful signal for partnerships and referral programs.